Abstract:Background Lung cancer is the most prevalent and lethal cancer globally, necessitating accurate differentiation between benign and malignant pulmonary nodules to guide treatment decisions. This study aims to develop a predictive model that integrates artificial intelligence (AI) analysis with biomarkers to enhance early detection and stratification of lung nodule malignancy. Methods The study retrospectively analyzed the patients with pathologically confirmed pulmonary nodules. AI technology was employed to assess CT features, such as nodule size, solidity, and malignancy probability. Additionally, lung cancer blood biomarkers were measured. Statistical analysis involved univariate analysis to identify significant differences among factors, followed by multivariate logistic regression to establish independent risk factors. The model performance was validated using receiver operating characteristic curves and decision curve analysis (DCA) for internal validation. Furthermore, an external dataset comprising 51 cases of lung nodules was utilized for independent validation to assess robustness and generalizability. Results A total of 176 patients were included, divided into benign/preinvasive ( n = 76) and invasive cancer groups ( n = 100). Multivariate analysis identified eight independent predictors of malignancy: lobulation sign, bronchial inflation sign, AI-predicted malignancy probability, nodule nature, diameter, solidity proportion, vascular endothelial growth factor, and lung cancer autoantibodies. The combined predictive model demonstrated high accuracy (area under the curve [AUC] = 0.946). DCA showed that the combined model significantly outperformed the traditional model, and also proved superior to models using AI-predicted malignancy probability or the seven lung cancer autoantibodies plus traditional model. External validation confirmed its robustness (AUC = 0.856), achieving a sensitivity of 0.80 and specificity of 0.86, effectively distinguishing between invasive and noninvasive nodules. Conclusion This combined approach of AI-based CT features analysis with lung cancer biomarkers provides a more accurate and clinically useful tool for guiding treatment decisions in pulmonary nodule patients. Further studies with larger cohorts are warranted to validate these findings across diverse patient populations. Received: 07 May 2024 Accepted: 01 October 2024 Article published online: 26 November 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

A Clinical-Information-Free Method for Early Diagnosis of Lung Cancer from the Patients with Pulmonary Nodules Based on Backpropagation Neural Network Model

A Radiomic Approach to Access Tumor Immune Status by CD8<SUP>+</SUP>TRMs on Surgically Resected Non-Small-Cell Lung Cancer

A Simple Method to Train the AI Diagnosis Model of Pulmonary Nodules.

Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data

A machine learning-based PET/CT model for automatic diagnosis of early-stage lung cancer

A Predictive Model Integrating AI Recognition Technology and Biomarkers for Lung Nodule Assessment

Highly accurate model for prediction of lung nodule malignancy with CT scans

Parse and Recall: Towards Accurate Lung Nodule Malignancy Prediction like Radiologists

A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy

Artificial neural network–based diagnostic models for lung cancer combining conventional indicators with tumor markers

Using a risk model for probability of cancer in pulmonary nodules

A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features

Explainable Classification of Benign-Malignant Pulmonary Nodules With Neural Networks and Information Bottleneck

Artificial intelligence neural network analysis and application of CT imaging features to predict lymph node metastasis in non-small cell lung cancer

Development and clinical application of deep learning model for lung nodules screening on CT images

Lung cancer detection using co-learning from chest CT images and clinical demographics

Identification of Pulmonary Nodules Via CT Images with Hierarchical Fully Convolutional Networks.

A cross-modal 3D deep learning for accurate lymph node metastasis prediction in clinical stage T1 lung adenocarcinoma

Research Progress in Predicting the Risk of Lymphatic or Hematologic Metastasis Based on Chest CT in Early Non- Small Cell Lung Cancer

CT and CEA‐based Machine Learning Model for Predicting Malignant Pulmonary Nodules